Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Futu Holdings Ltd (FUTU) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Futu Holdings LtdTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Futu Holdings Ltd vs State Street SPDR S&P Biotech ETF — how do they compare? Futu Holdings Ltd trades at $105.88 (market cap $14.74B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Futu Holdings Ltd pays a 2.47% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Futu Holdings Ltd nearer its low. Which is the better fit depends on your goals.

FUTUXBI
Market Cap
$14.74B
Sector
FinancialsBroad Market / Factor
52-Week High
$199.04$164.28
52-Week Low
$89.76$86.92
Enterprise Value
$14.59B
Dividend Yield
2.47%

Returns comparison

Trailing returns across standard periods

About Futu Holdings Ltd

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Read more on FUTU

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI